...
CIPM 2026 Q&A cover: pellet and 3-in-1 granulation at JIANPAI booth
CIPM 2026: perguntas e respostas sobre granulação centrífuga versus extrusão e o granulador 3-em-1
From October 27 to 29, 2026, the 68th China National Pharmaceutical Machinery Expo (CIPM 2026) filled...
CIPM 2026 Q&A cover: smart OSD, mixing and coating at JIANPAI booth 2-B27
CIPM 2026: Perguntas e respostas sobre produção inteligente de OSD, mistura triplo-excêntrica e revestimento
At CIPM 2026 in Xiamen (October 27-29, 2026), visitors to JIANPAI Booth 2-B27 did not ask for brochures....
JianPai Technology team at CIPM 2026 Xiamen
JianPai Technology conclui com êxito a participação na CIPM 2026 em Xiamen
JianPai Technology wraps up CIPM 2026 Xiamen at Booth 2-B27 (Oct 27–29): fluid bed and high-shear granulators,...
Top generic pharma manufacturing companies in Indonesia 2026 B2B shortlist cover with JIANPAI fluid bed equipment
Principais fabricantes de medicamentos genéricos na Indonésia: lista resumida B2B 2026
Indonesia’s generics market is shaped by BPOM licensing, CPOB (GMP) expectations, and JKN / e-catalogue...

SOBRE NÓS

Sobre nós - apresentando nossa equipe,
missão e valores.

Ranking 2026 das 50 maiores farmacêuticas do mundo

Ranking 2026 das 50 maiores farmacêuticas do mundo

The global pharmaceutical industry continues to experience strong growth driven by innovation in biologics, oncology, diabetes and obesity treatment, vaccines, and rare disease therapies. In August 2026, Pharm Exec magazine published the 2026 Pharm Exec 50, ranking the Top 50 pharmaceutical companies worldwide by prescription drug (Rx) sales in fiscal year 2025.

This ranking is widely regarded as one of the most authoritative industry benchmarks, offering valuable insight for pharmaceutical manufacturers, API and packaging suppliers, pharmaceutical equipment companies, and distributors and contract manufacturing organizations (CMOs).

Below is the fully updated 2026 Global Top 50 Pharmaceutical Companies List, based on 2025 Rx sales.

Metodologia de classificação

  • Fonte de classificação: Pharm Exec magazine (2026 Pharm Exec 50, published August 14, 2026)
  • Base de classificação: Global prescription drug (Rx) sales
  • Ano fiscal: 2025
  • Ano de lançamento da classificação: 2026

Esta classificação reflete desempenho comercial real, not market capitalization or valuation. Figures in the table are 2025 Rx sales, shown in US$ billion.

2026 Global Top 50 Pharmaceutical Companies (Complete List)

Classificação Empresa Sede 2025 Rx sales (US$ billion)
1 Eli Lilly EUA 60.78
2 Johnson & Johnson EUA 59.33
3 AbbVie EUA 58.27
4 Roche Suíça 57.51
5 AstraZeneca Reino Unido 55.04
6 Merck & Co. (MSD) EUA 54.69
7 Novartis Suíça 54.33
8 Pfizer EUA 49.91
9 Sanofi França 48.97
10 Bristol-Myers Squibb EUA 47.75
11 Novo Nórdico Dinamarca 46.80
12 GSK (GlaxoSmithKline) Reino Unido 42.72
13 Amgen EUA 34.95
14 Takeda Japão 29.67
15 Ciências de Gileade EUA 28.83
16 Boehringer Ingelheim Alemanha 23.82
17 Bayer Alemanha 19.19
18 CSL Austrália 15.44
19 Viatris EUA 14.09
20 Teva Israel 14.08
21 Astellas Japão 12.60
22 Daiichi Sankyo Japão 12.04
23 Farmacêutica Vertex EUA 11.97
24 Grupo Sandoz Suíça 11.09
25 Participações Otsuka Japão 9.87
26 Merck KGaA Alemanha 9.73
27 UCB Bélgica 8.24
28 Grifols Espanha 7.33
29 Biogênio EUA 7.12
30 Sol Farmacêutica Índia 6.44
31 Regeneron EUA 6.31
32 Organon EUA 6.06
33 Yunnan Baiyao China 5.72
34 Abbott EUA 5.51
35 Servidor França 5.44
36 Bausch Health Canadá 5.41
37 BeOne Medicines (formerly BeiGene) Suíça 5.28
38 Fresenius Alemanha 5.21
39 Shanghai Pharmaceuticals China 5.16
40 Eisai Japão 4.78
41 Sino Biopharmaceutical Hong Kong 4.37
42 Menarini Itália 4.36
43 Incitar EUA 4.35
44 Ipsen França 4.16
45 argenx Holanda 4.15
46 Jazz Farmacêutica Irlanda 4.02
47 STADA Alemanha 4.02
48 Medicina Huadong China 3.97
49 Medicina de Jiangsu Hengrui China 3.85
50 Haleon Reino Unido 3.60

Data source: Pharm Exec, 2026 Pharm Exec 50 (FY 2025 prescription drug sales). Company names use common English forms; BeOne Medicines appears under its current name (formerly BeiGene).

Key Industry Trends from the 2026 Ranking

1. Eli Lilly Rises to No. 1

The headline change this year is Eli Lilly’s jump from No. 11 in the previous ranking to No. 1, with about $60.8 billion in 2025 Rx sales, up roughly 49% year over year. Johnson & Johnson, last year’s leader, is now No. 2. AbbVie, Roche, and AstraZeneca complete the top five.

2. U.S. Companies Continue to Lead by Count

Fifteen companies in the Top 50 are headquartered in the United States, still the largest national group, with particular strength in oncology, immunology, biologics, and metabolic disease, including GLP-1 therapies.

3. Switzerland, Japan, and Germany Remain Innovation Hubs

Switzerland is represented by Roche, Novartis, Sandoz, and BeOne Medicines (formerly BeiGene, now listed with a Swiss headquarters). Japan remains well represented by Takeda, Astellas, Daiichi Sankyo, Otsuka, and Eisai. Germany includes Boehringer Ingelheim, Bayer, Merck KGaA, Fresenius, and STADA.

4. China Holds Five Places; India Is Represented by Sun Pharma

Five Chinese companies are in this year’s list if Sino Biopharmaceutical (Hong Kong) is included: Yunnan Baiyao, Shanghai Pharmaceuticals (a new entrant), Sino Biopharmaceutical, Huadong Medicine, and Jiangsu Hengrui Medicine. CSPC Pharmaceutical Group is no longer in the Top 50. From India, Sun Pharma remains on the list; Dr. Reddy’s Laboratories is not in this year’s Top 50. New global entrants also include argenx (Netherlands) and Haleon (UK).

Por que esta classificação é importante para fornecedores farmacêuticos

If you are involved in pharmaceutical machinery manufacturing, packaging solutions (vials, bottles, blister, ampoules), API and excipient supply, or contract manufacturing (CDMO/CMO), this list directly reflects where purchasing power is concentrated, which companies control global drug production, and who your most valuable long-term customers may be.

Outlook for the Global Pharmaceutical Industry in 2026

Based on this ranking, the pharmaceutical industry will continue focusing on biologics and biosimilars, GLP-1 diabetes and obesity drugs, cancer immunotherapy, rare disease treatments, and personalized medicine. Companies at the top of the 2026 Pharm Exec 50 are expected to drive mergers and acquisitions, equipment upgrades, and new plant investments worldwide.

What Equipment Do These Pharma Leaders Use?

Most companies in this ranking run large oral solid dosage (OSD) operations alongside biologics. Their tablet and capsule plants are built around a similar process chain, and each step needs GMP-grade equipment that produces repeatable batches. We cover this in detail in what equipment the global Top 50 pharma companies use to ensure quality.

Process step Propósito Related JIANPAI equipment
Granulação úmida Densify powders and improve flow and content uniformity Granuladores misturadores de alto cisalhamento (JHZ-C, JHZ-D)
Secagem Reduce granule moisture to the validated level Fluid bed dryers (JFG-C)
Sizing and milling Control particle size before blending Pharma mills (Granulador de dimensionamento JZL)
Blending Mix granules with lubricants and excipients Pharma blenders (Misturador de três excentricidades JPH)
Revestimento Film, sugar or enteric coating of tablets Máquinas de revestimento de comprimidos (JGB-D, JGB-E)
Integrated lines Closed, linked granulation lines that reduce manual handling Totally enclosed granulating production line, fabricação contínua

Generic and contract manufacturers that supply these leaders, or compete with them, often benchmark their own lines against the same standards. For budget planning, see our guia de preços da máquina de revestimento de comprimidos.

Conclusão

O 2026 Global Top 50 Pharmaceutical Companies Ranking provides a clear overview of the world’s leading drug manufacturers, based on 2025 prescription drug sales, and reflects the direction of the global pharmaceutical industry. From biologics and oncology to diabetes, obesity, and rare disease therapies, these top companies will continue to drive innovation, capacity expansion, and equipment upgrades worldwide.

Como fabricante profissional de máquinas farmacêuticas, Jianpai closely follows the development trends of these global pharma leaders and is committed to providing reliable, high-efficiency production and processing solutions for pharmaceutical manufacturers across the world. Whether you are planning a new production line, upgrading existing equipment, or expanding your formulation and packaging capacity, JIANPAI offers customized solutions to meet your exact needs.

Perguntas frequentes

Who is the largest pharmaceutical company in the 2026 ranking?

Eli Lilly is No. 1 in the 2026 Pharm Exec 50, with about $60.8 billion in 2025 prescription (Rx) drug sales. Johnson & Johnson is No. 2. The complete Top 50 table above ranks companies by 2025 Rx sales, as described in the methodology section.

What equipment do top pharmaceutical companies use for oral solid dosage?

Large OSD plants typically run high shear wet granulation, fluid bed drying, milling and sizing, blending, tablet compression, and film or functional coating, often with closed material transfer and automated cleaning.

Why does this ranking matter for equipment suppliers?

Top companies set the quality and compliance expectations that generic and contract manufacturers follow. Equipment that meets their GMP, data integrity and containment needs is increasingly expected across the industry.

Planning an OSD line to global standards?

JIANPAI supplies granulation, drying, milling, blending and coating equipment for oral solid dosage plants. Send us your products and target capacity for a line proposal.

E-mail: [email protected] | Telefone: +86 577-86932456 | Nº 989 Lingde Road, Novo Distrito de Oujiangkou, Wenzhou, Zhejiang, China

pt_PTPT

Conte -nos o seu Requisitos Questões Precisa Idéias Planos